Tranexamic acid (TXA) is an antifibrinolytic agent that inhibits clot breakdown and is well described in the literature toreduce intraoperative blood loss in craniofacial, cardiac, trauma, dermatologic, and orthopedic surgeries.

Tranexamic acid (TXA) is an antifibrinolytic agent that inhibits clot breakdown and is well described in the literature toreduce intraoperative blood loss in craniofacial, cardiac, trauma, dermatologic, and orthopedic surgeries.
Recent prospective clinical studies have not found an increased incidence of facial scarring in patients using isotretinoin in the perioperative period.
There is no meaningful advantage to justify using tranexamic acid as a best practice measure in rhytidectomy.
Both septoplasty and rhinoplasty are associated with mostly mild pain, and postoperative opioid requirements are quite low.
Given the lack of reliability of the Schirmer’s Test, it is not essential in the preoperative evaluation of blepharoplasty patients.
A look at the ideal methods of skin preparation to reduce surgical site infection (SSI) in head and neck surgery.
Facelift techniques have evolved over the years, and modifications will continue into the future in pursuit of producing the best long-lasting aesthetic results.
The suggests attempting preoperative steroid injections prior to proceeding with surgical excision
Leech therapy is a temporary modality to decrease skin flap venous congestion until further revascularization occurs for venous outflow
The most commonly used adjunctive measures are drain placement, application of tissue sealant, and use of compression dressings